CRACK IT Challenge 36: Winners Phase 2

Date
Category
Reading Time
10 minutes

Following successful completion of the Phase 1 challenge awarded to ImmuONE by NC3Rs, we were announced as the winners for the Phase 2 challenge in January 2022. Sponsored by Unilever and AstraZeneca, the project aims to establish and develop in vitro OECD test guideline assays; free from animal-derived products and demonstrate their equivalence and superiority to current strategies. Once optimised, these technologies will progress to commercially ready, human relevant, animal-free bioassays with the view of gaining regulatory acceptance. 

Add a Comment

Related Posts

From microbiology to biotech: Meet Brendon

Brendon Ghiot, our Senior Scientist at ImmuONE, joins us for a coffee to share his diverse journey from working in cellular biology to pioneering in CAR-T therapy for cancer treatment. Brendon tells us what drives his interest in developing new technologies at ImmuONE, particularly in animal-free inhalation toxicity testing.

Joining ImmuONE: Insights from Jo

In our most recent coffee chat, we caught up with Jo Kelsall, our new lead commercial scientist. Jo shared with us her unique career spanning the realms of science and law while also giving us the inside scoop on what life has been like so far at ImmuONE!

ImmuONE featured on ITV News

Gender equality in the biotech industry has come a long way in recent years. In the UK, the US and Europe, women now make up between 40-50% of the biotech workforce, which is a higher percentage than in other STEM fields, such as engineering and the physical sciences.

Scroll to Top